Literature DB >> 21074758

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States.

David B Seifer1, Valerie L Baker, Benjamin Leader.   

Abstract

OBJECTIVE: To determine age-specific serum anti-Müllerian hormone (AMH) values for women presenting to U.S. fertility clinics.
DESIGN: Retrospective study.
SETTING: Single clinical reference laboratory. PATIENT(S): A total of 17,120 women of reproductive age ranging from 24 to 50 years old. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Determination of single-year median and mean AMH values with SDs. RESULT(S): Single-year-specific median, mean, and SD values are summarized in Table 1. Both median and mean AMH values decreased steadily in a manner highly correlated with advancing age. The average yearly decrease in the median serum AMH value was 0.2 ng/mL/year through age 35 and then diminished to 0.1 ng/mL/year after age 35. The rate of decline in mean AMH values was 0.2 ng/mL/year through age 40 and then diminished to 0.1 ng/mL/year thereafter. CONCLUSION(S): Median and mean AMH levels decreased steadily with increasing age from 24 to 50 years of age. Such data may be of value to physicians and their patients who are considering reproductive options.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074758     DOI: 10.1016/j.fertnstert.2010.10.011

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  82 in total

1.  Anti-Müllerian hormone: a potential new tool in epidemiologic studies of female fecundability.

Authors:  Donna D Baird; Anne Z Steiner
Journal:  Am J Epidemiol       Date:  2012-01-12       Impact factor: 4.897

2.  Different ovarian response by age in an anti-Müllerian hormone-matched group undergoing in vitro fertilization.

Authors:  Hiroyuki Honnma; Tsuyoshi Baba; Masahiro Sasaki; Yoshiki Hashiba; Hisanori Oguri; Takanori Fukunaga; Toshiaki Endo; Yoshimasa Asada
Journal:  J Assist Reprod Genet       Date:  2011-11-16       Impact factor: 3.412

3.  Impact of cancer therapies on ovarian reserve.

Authors:  Clarisa R Gracia; Mary D Sammel; Ellen Freeman; Maureen Prewitt; Claire Carlson; Anushree Ray; Ashley Vance; Jill P Ginsberg
Journal:  Fertil Steril       Date:  2011-12-02       Impact factor: 7.329

4.  The original Beckman Coulter Generation II assay significantly underestimates AMH levels compared with the revised protocol.

Authors:  Michael Bonifacio; Cara K Bradley; Sonal Karia; Mark Livingstone; Mark C Bowman; Steven J McArthur
Journal:  J Assist Reprod Genet       Date:  2015-10-14       Impact factor: 3.412

5.  Anti-Mullerian hormone normogram in an Irish subfertile population.

Authors:  M N Naasan; C Harrity; L Pentony; E Mocanu
Journal:  Ir J Med Sci       Date:  2014-02-23       Impact factor: 1.568

6.  Obesity adversely affects serum anti-müllerian hormone (AMH) levels in Caucasian women.

Authors:  Vicky Moy; Sangita Jindal; Harry Lieman; Erkan Buyuk
Journal:  J Assist Reprod Genet       Date:  2015-07-21       Impact factor: 3.412

7.  Post-chemotherapy serum anti-müllerian hormone level predicts ovarian function recovery.

Authors:  Hyun-Ah Kim; Jihye Choi; Chan Sub Park; Min-Ki Seong; Sungeun Hong; Jae-Sung Kim; In-Chul Park; Jin Kyung Lee; Woo Chul Noh
Journal:  Endocr Connect       Date:  2018-07-16       Impact factor: 3.335

8.  Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103.

Authors:  Kathryn J Ruddy; Anne O'Neill; Kathy D Miller; Bryan P Schneider; Emily Baker; Joseph A Sparano; Chau Dang; Donald W Northfelt; George W Sledge; Ann H Partridge
Journal:  Breast Cancer Res Treat       Date:  2014-03-02       Impact factor: 4.872

9.  One-year impact of bariatric surgery on serum anti-Mullerian-hormone levels in severely obese women.

Authors:  Clara Vincentelli; Marie Maraninchi; René Valéro; Sophie Béliard; Flavia Maurice; Olivier Emungania; Bruno Berthet; Elise Lombard; Anne Dutour; Bénédicte Gaborit; Blandine Courbiere
Journal:  J Assist Reprod Genet       Date:  2018-05-12       Impact factor: 3.412

10.  Disruptions in ovarian function are related to depression and cardiometabolic risk during premenopause.

Authors:  Maria E Bleil; Joyce T Bromberger; Melissa D Latham; Nancy E Adler; Lauri A Pasch; Steven E Gregorich; Mitchell P Rosen; Marcelle I Cedars
Journal:  Menopause       Date:  2013-06       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.